Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-867-5 | CAS number: 111-41-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
- Reference Type:
- publication
- Title:
- Malformations of the Great Vessels in the Neonatal Rat Induced by N-(2-Aminoethyl)ethanolamine
- Author:
- Schneider et al.
- Year:
- 2 012
- Bibliographic source:
- Birth Defects Research (Part B) 95:95–106 (2012)
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 421
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other: OPPTS 870.3550
- Deviations:
- not specified
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 2-(2-aminoethylamino)ethanol
- EC Number:
- 203-867-5
- EC Name:
- 2-(2-aminoethylamino)ethanol
- Cas Number:
- 111-41-1
- Molecular formula:
- C4H12N2O
- IUPAC Name:
- 2-[(2-aminoethyl)amino]ethan-1-ol
- Details on test material:
- - Physical state: liquid (colorless clear)
- Analytical purity: 99.8 %, had been verified by reanalysis prior to the study commencing
- Lot/batch No.: continuous operation
- Stability: The storage stability under storage conditions was confirmed by reanalysis (analytical report 05L00199).
- Storage condition of test material: stored at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH (former name: Charles River Laboratories, Germany)
- Age at study initiation: 11 - 12 weeks old
- Weight at study initiation: 242 - 295 g (males), 176 - 218 g (females)
- Housing: singly in type DK III stainless steel wire mesh cages supplied by Becker & Co., Castrop-Rauxel, Germany (floor area of about 800 cm²), with the following exceptions: for the overnight mating the females were put into the cages of the males; from day 18 p.c. until day 4 p.p. the pregnant animals and their litters were housed in Makrolon type M III cages (floor area about 800 cm²). The M III cages were also supplied by Becker & Co.. Pregnant females were provided with nesting material (cellulose wadding) toward the end of pregnancy.
- Diet: ground Kliba maintenance diet mouse/rat “GLP”, meal, supplied by Provimi Kliba SA, Kaiseraugst, Switzerland, ad libitum
- Water: ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): air-conditioned, 20 - 24 °C
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12 hours / 12 hours
IN-LIFE DATES: From: 18 October 2005 To: 13 December 2005
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
For the preparation of the administration solutions the test substance was weighed in a graduated measuring flask depending on the dose group, topped up with doubly distilled water and subsequently thoroughly mixed using a magnetic stirrer. The test substance solutions were prepared at the beginning of the administration period and thereafter at intervals that took into account the stability of the test substance preparation.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analytical verifications of the stability of the test substance in drinking water (“Frankenthaler Leitungswasser”) for a period of 10 days at room temperature were carried out before the study was initiated. Given that AEEA is completely miscible with water, solutions were considered to be homogenous without further analysis. Samples of the aqueous test substance solutions were sent to the analytical laboratory twice during the study period for verification of the concentrations.
- Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: 1:1
- Length of cohabitation: overnight at least 13 days after start of treatment
- Verification of same strain and source of both sexes: yes. According to a written statement from the breeder, male and female animals were derived from different litters. This was necessary to rule out the possibility of sibling mating.
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy
- Any other deviations from standard protocol: male animal No. 87 of dose group 3 (5 mg/kg bw/day) was mated with two female animals of dose group 3 (Nos. 287 and 288), because of the preterminal death of one male animal No. 88 of dose group 3). - Duration of treatment / exposure:
- 38 days (males), 54 days (females)
- Frequency of treatment:
- 7 times/week
- Duration of test:
- 54 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 0.2, 1, 5, 50 mg/kg bw/day
Basis:
nominal conc.
- No. of animals per sex per dose:
- 25 rats
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale:
The following dose levels were selected:
0.2 and 1 mg/kg bw/day: as doses covering a 2-fold range below NOAEL in low power probe study in effort to find NOAEL given increased statistical power of present study
5 mg/kg bw/day: NOAEL in low statistical power probe study
50 mg/kg bw/day: bridging dose where effect of interest was seen in other studies.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS:
- Time schedule: at least daily
BODY WEIGHT:
- Time schedule for examinations: In general, the body weight of the male and female parental animals was determined once a week at the same time of the day (in the morning). The body weight change of the animals was calculated from these results. The following exceptions are notable for the female animals: During the mating period the parental females were weighed on days 0, 7, 14 and 20 post coitum. Females with litter were weighed on days 0 and 4 post partum. Females without litter, waiting for necropsy, were weighed weekly.
FOOD CONSUMPTION
- Time schedule: Generally, food consumption was determined once a week for parental animals, with the following exceptions: food consumption was not determined during the mating period (male and female F0 animals). Food consumption of the F0 females with evidence of sperm was determined on days 0, 7, 14 and 20 post coitum. Food consumption of F0 females, which gave birth to a litter was determined on days 0 and 4 post partum.
POST-MORTEM EXAMINATIONS:
Females were allowed to litter and rear their pups until day 4 p.p.; thereafter the parental females were sacrificed. - Fetal examinations:
- not applicable
- Statistics:
- Weight parameters were analyzed using the two-sided Kruskal-Wallis test, followed by the Wilcoxon test if the p-value was =/< 0.05.
Proportions of affected pups per litter with necropsy observations was analyzed using the one-sided Wilcoxon test. - Indices:
- Male mating and fertility, and female mating, fertility and gestation indices were determined. Live birth index and post implantation loss were assessed.
- Historical control data:
- Historical control data were included in the report.
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
Parental clinical examinations: Mortality: there was no substance-related mortality in any of the male and female animals in any of the dose groups. Clinical signs: there were no changes noted in male or female animals. Clinical signs during gestation (females): there were no substance-related clinical observations. There were several sperm-positive rats of the treated groups which did not deliver F1 pups (1/1/3 in groups at 0.2/5/50 mg/kg bw/day, respectively). This was not considered to be associated with the test compound. Clinical signs during lactation (females): there were no substance-related clinical observations. Food consumption: there was no difference between treated and control male and female groups. Body weight: there was no difference between treated and control male and female groups. Male fertility index: one low dose male and two high dose males did not generate pups. Thus the male fertility index was 100/96/100/100/92 % in the groups at 0/0.2/1/5/50 mg/kg bw/day, respectively, which was within the normal range of biological variation. Sperm parameters: no treatment-related effects were noted for the sperm parameters, examined at or after the sacrifice of the F0 parental males. The number of homogenization resistant testicular spermatids or caudal epididymal sperm, the percentages of abnormal and normal sperm and sperm motility data were similar between the examined test substance-treated groups and the concurrent control group (0, 0.2, 1, 5 and 50 mg/kg bw/day) and did not show any biologically or statistically significant differences.
The female fertility index was 100/96/100/100/92 % in the groups at 0/0.2/1/5/50 mg/kg bw/day, respectively, which was within the range of historical control data. The duration of gestation was similar in all test groups, i.e. 21.9 to 22.0 days. The gestation index was 100/100/100/96/96 % in the groups at 0/0.2/1/5/50 mg/kg bw/day, respectively. Implantation was not affected as the number of implantation sites was comparable between all control and treated groups. There was no indication of intrauterine embryo-fetolethality, as the postimplantation loss showed no statistically significant differences between the groups. The rate of liveborn pups was 99 % in the control and test groups at 0.2 to 5 mg/kg bw/day and 100 % in the treatment group at 50 mg/kg bw/day. The number of stillborn pups was comparable between the groups.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 50 mg/kg bw/day
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
The mean number of delivered pups per dam was comparable between all groups. The viability index on day 4 after birth (post parturition, p.p.) was 99 % in all groups. There was no biologically relevant difference in the sex ratio between control and test groups. There were no clinical signs noted on day 4 p.p. in any group. There was no statistically significant difference in pup body weight between control and test groups, including the number of stunted pups. The macroscopic examination of all pups at necropsy revealed a number of findings in the pericardial vessels, which were considered to be test substance-induced (see "Remarks on results including tables and figures"). Additionally, a few of the examined F1 pups showed some spontaneous findings at necropsy (e.g. post mortem autolysis, hemorrhagic thymus, short innominate, dilated innominate, long innominate, dextrocardia, enlarged atrial chamber, absent atrial chamber) scattered throughout the test substance-treated groups and the control. These findings occurred without a clear relation to dosing and/or most of it can be found in the historical control data at comparable or even higher incidences. The histopathological examination revealed aneurysms and focal hemorrhages of the major pericardial blood vessels. Aneurysms occurred at all tested dose levels (see "Remarks on results including tables and figures").
The female fertility index was 100/96/100/100/92 % in the groups at 0/0.2/1/5/50 mg/kg bw/day, respectively, which was within the range of historical control data. The duration of gestation was similar in all test groups, i.e. 21.9 to 22.0 days. The gestation index was 100/100/100/96/96 % in the groups at 0/0.2/1/5/50 mg/kg bw/day, respectively. Implantation was not affected as the number of implantation sites was comparable between all control and treated groups. There was no indication of intrauterine embryo-fetolethality, as the postimplantation loss showed no statistically significant differences between the groups. The rate of liveborn pups was 99 % in the control and test groups at 0.2 to 5 mg/kg bw/day and 100% in the treatment group at 50 mg/kg bw/day. The number of stillborn pups was comparable between the groups.
Effect levels (fetuses)
- Dose descriptor:
- LOAEL
- Effect level:
- 0.2 mg/kg bw/day
- Basis for effect level:
- other: embryotoxicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Developmental toxicity was noted at dose levels without maternal toxicity.
|
|||||
|
|||||
INCIDENCES OF SELECTED PERICARDIAL VESSEL FINDINGS IN PUPS |
|||||
|
|||||
Finding |
Dose Group [mg/kg bw/day] |
||||
|
0 |
0.2 |
1 |
5 |
50 |
All animals |
|||||
Animals [n] |
304 |
298 |
319 |
288 |
270 |
Dissecting aneurysm#[n] |
0 |
2 |
1 |
1 |
60 |
(Multi) focal hemorrhage [n] |
1 |
1 |
2 |
3 |
4 |
Increased thickness of adventitial layer [n] |
0 |
0 |
0 |
0 |
5 |
Males |
|||||
Animals [n] |
156 |
148 |
159 |
132 |
125 |
Dissecting aneurysm#[n] |
0 |
0 |
0 |
0 |
26 |
(Multi) focal hemorrhage [n] |
1 |
0 |
0 |
2 |
2 |
Increased thickness of adventitial layer [n] |
0 |
0 |
0 |
0 |
0 |
Females |
|||||
Animals [n] |
148 |
150 |
160 |
156 |
145 |
Dissecting aneurysm#[n] |
0 |
2 |
1 |
1 |
34 |
(Multi) focal hemorrhage [n] |
0 |
1 |
2 |
1 |
2 |
Increased thickness of adventitial layer [n] |
0 |
0 |
0 |
0 |
5 |
#: Summary of animals with one or more aneurysms of major pericardial blood vessel locations (aorta, pulmonary trunk, ductus arteriosus, innominate arteria). |
|||||
|
|||||
|
OCCURRENCE OF PERICARDIAL VESSEL FINDINGS IN PUPS# |
||||
|
||||
Finding |
Dose Group [mg/kg bw/day] |
|||
[mean % of affected pups/litter] |
0.2 |
1 |
5 |
50 |
|
||||
Dilated descending aorta |
0 |
0 |
0 |
9.8** |
Aneurysm of descending aorta |
0 |
0 |
0 |
4.4** |
Dilated pulmonary trunk |
0 |
0 |
0 |
0.3 |
Aneurysm of ductus arteriosus |
0 |
0.4 |
0.3 |
8.1** |
Aneurysm of pulmonary trunk |
0 |
0 |
0 |
2.8** |
Malpositioned subclavial branch |
0.3 |
0 |
0 |
2.3** |
Aneurysm of aortic arch |
0 |
0 |
0 |
1.7** |
Dilated aortic arch |
0 |
0 |
0 |
0.3 |
#: The incidence of all these findings was 0 in the control group; **: p < 0.01 |
Applicant's summary and conclusion
- Executive summary:
In this developmental toxicity study, N-(2 -aminoethyl)ethanolamine (AEEA) was administered orally by gavage to groups of 25 male and 25 female Wistar rats at doses of 0.2, 1, 5 or 50 mg/kg bw/day in order to detect possible effects of the test substance on the great pericardial blood vessels of both sexes when exposed during prenatal and postnatal development. Control animals were dosed daily with the vehicle (doubly distilled water). The duration of treatment covered a 2 week premating period and mating in both sexes, approximately 2 weeks post-mating in males, as well as entire gestation and 4 days of lactation period in females. The NOAEL for general, systemic toxicity of the test substance was 50 mg/kg bw/day for the parental animals. The NOAEL for reproductive performance and fertility was 50 mg/kg bw/day for the F0 parental rats. A NOAEL for developmental toxicity in the F1 progeny was not determined because aneurysms of the pericardial vessels occurred at all tested dose levels. The LOAEL was therefore 0.2 mg/kg bw/day under the conditions of this reproduction/developmental screening test. Further, hemorrhages of the pericardial blood vessels were seen in all dose groups including the controls (one male affected). Hemorrhages are regarded to be precursor lesions of aneurysms, which can also develop in untreated animals, which was demonstrated by the observed case. The observation of blood vessel lesions in untreated animals is important, because this prevents the determination of NOAEL or LOAEL values. The pericardial blood vessels are not routinely examined in repeated dose studies such as OECD TG 421/422 studies. Consequently, there is no historical control database which would allow to judge whether the effects seen in the treated groups are within or above the historical control range. Therefore, a treatment-related NOAEL for developmental toxicity in the F1 progeny could not be derived in this study. In the absence of a reliable historical control database the same problem arises regarding the setting of a LOAEL, because there was one case of hemorrhage, thought to be a precursor of aneurysm, in an untreated animal. It is therefore necessary to establish a historical control database. It should be further mentioned that the dose-response curve was rather low in the range from 0 to 5 mg/kg bw/day and that there was a steep increase at 50 mg/kg bw/day, based on the cumulated percentage of animals showing either aneurysms, hemorrhage, or an increased thickness of the adventitial layers (0.33/1.01/1.57/1.39/25.5% in groups at 0/0.2/1/5/50 mg/kg bw/day, respectively). Overall, developmental toxicity was noted at all dose levels without maternal toxicity at any dose level. A clearly increased incidence of blood vessel lesions was seen at 50 mg/kg bw/day, whereas it cannot be determined whether the incidence of lesions observed in the dose range from 0.2 to 5 mg/kg bw/day is comparable or increased compared to untreated control animals.
This developmental toxicity study in the rat with a special focus on damage to vessels mainly in the form of aneurysms (best examined shortly after birth) is classified acceptable and satisfies the guideline requirement for a developmental toxicity study (OPPTS 870.3550; OECD 421) in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.